Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$101M Sell
2,977,304
-702,776
-19% -$25.6M 0.53% 38
2019
Q2
$151M Buy
3,680,080
+18,825
+0.5% +$748K 0.79% 18
2019
Q1
$148M Sell
3,661,255
-100,751
-3% -$4.03M 0.78% 19
2018
Q4
$156M Sell
3,762,006
-110,307
-3% -$4.58M 0.9% 18
2018
Q3
$162M Buy
3,872,313
+47,795
+1% +$1.84M 0.84% 17
2018
Q2
$132M Buy
3,824,518
+121,712
+3% +$4.16M 0.72% 22
2018
Q1
$125M Buy
3,702,806
+208,835
+6% +$7.18M 0.7% 22
2017
Q4
$120M Sell
3,493,971
-147,770
-4% -$5.04M 0.7% 22
2017
Q3
$123M Sell
3,641,741
-19,000
-0.5% -$611K 0.73% 22
2017
Q2
$117M Buy
3,660,741
+9,747
+0.3% +$307K 0.71% 24
2017
Q1
$119M Sell
3,650,994
-457,041
-11% -$14.4M 0.76% 24
2016
Q4
$127M Sell
4,108,035
-84,957
-2% -$2.59M 0.76% 23
2016
Q3
$135M Sell
4,192,992
-30,778
-0.7% -$1.03M 0.84% 21
2016
Q2
$141M Buy
4,223,770
+72,978
+2% +$2.33M 0.86% 20
2016
Q1
$117M Buy
4,150,792
+84,238
+2% +$2.41M 0.72% 26
2015
Q4
$125M Buy
4,066,554
+39,157
+1% +$1.23M 0.77% 24
2015
Q3
$120M Buy
4,027,397
+33,549
+0.8% +$1.08M 0.81% 18
2015
Q2
$127M Buy
3,993,848
+5,816
+0.1% +$190K 0.82% 20
2015
Q1
$132M Buy
3,988,032
+275,144
+7% +$8.75M 0.85% 17
2014
Q4
$110M Sell
3,712,888
-312,961
-8% -$8.97M 0.74% 26
2014
Q3
$113M Sell
4,025,849
-325,239
-7% -$9.13M 0.79% 25
2014
Q2
$123M Sell
4,351,088
-3,442,099
-44% -$98.1M 0.85% 21
2014
Q1
$237M Sell
7,793,187
-21,406
-0.3% -$638K 0.87% 13
2013
Q4
$227M Buy
7,814,593
+26,183
+0.3% +$762K 0.88% 11
2013
Q3
$212M Buy
7,788,410
+1,254,047
+19% +$34.1M 0.83% 13
2013
Q2
$174M Buy
+6,534,363
New +$181M 0.77% 15

Other funds holding PFE

Suntrust Banks's PFE Position: Q3 2019 in Review

Suntrust Banks reduced its Pfizer (PFE) stake by 19% in Q3 2019, selling an estimated $25.6M and leaving 2,977,304 shares worth $101M. The position accounts for 0.53% of the portfolio, ranked #38.

Suntrust Banks first reported a position in PFE in Q2 2013 and has held it in 26 quarters since. The position peaked at $237M in Q1 2014. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Suntrust Banks held 2,977,304 shares of Pfizer worth $101M as of Q3 2019.
  • Suntrust Banks sold 702,776 Pfizer shares in Q3 2019, an estimated $25.6M.
  • Pfizer made up 0.53% of Suntrust Banks's portfolio in Q3 2019, its #38 holding.
  • Suntrust Banks first reported a position in Pfizer in Q2 2013 and has held it in 26 quarters since.
  • Suntrust Banks's Pfizer position peaked at $237M in Q1 2014.
  • 2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.